Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,700
Closed -$273K 2568
2021
Q4
$273K Buy
+5,700
New +$256K ﹤0.01% 3701
2021
Q3
Sell
-10,000
Closed -$452K 4188
2021
Q2
$452K Buy
+10,000
New +$468K ﹤0.01% 3190
2020
Q2
Sell
-13,700
Closed -$124K 2892
2020
Q1
$124K Buy
13,700
+2,700
+25% +$54.4K ﹤0.01% 2799
2019
Q4
$234K Buy
11,000
+200
+2% +$4.44K ﹤0.01% 3339
2019
Q3
$248K Sell
10,800
-27,300
-72% -$622K ﹤0.01% 3073
2019
Q2
$925K Buy
+38,100
New +$784K ﹤0.01% 1998
2018
Q4
Sell
-33,000
Closed -$1.3M 2917
2018
Q3
$1.3M Buy
33,000
+12,200
+59% +$550K ﹤0.01% 1793
2018
Q2
$1.02M Sell
20,800
-16,400
-44% -$930K ﹤0.01% 2134
2018
Q1
$2.22M Buy
37,200
+30,200
+431% +$2.01M 0.01% 1446
2017
Q4
$551K Buy
+7,000
New +$565K ﹤0.01% 2371

Other funds holding ADNT

John Overdeck's ADNT Position: Q2 2026 in Review

John Overdeck reduced its Adient (ADNT) stake by 77% in Q2 2026, selling an estimated $11.8M and leaving 163,398 shares worth $3M. The position accounts for ﹤0.01% of the portfolio, ranked #2626.

John Overdeck first reported a position in ADNT in Q4 2016 and has held it in 29 quarters since. The position peaked at $25.9M in Q3 2017. 311 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • John Overdeck held 163,398 shares of Adient worth $3M as of Q2 2026.
  • John Overdeck sold 552,931 Adient shares in Q2 2026, an estimated $11.8M.
  • Adient made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2626 holding.
  • John Overdeck first reported a position in Adient in Q4 2016 and has held it in 29 quarters since.
  • John Overdeck's Adient position peaked at $25.9M in Q3 2017.
  • 311 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.